Wednesday, May 29, 2024
24bc banner ep en 696x86 copy

MARPOSS eyes India’s thriving biomedical market

Subscribe to YouTube Channel

Subscribe to Mojo4Industry YouTube Channel and get Latest Industry Updates. Do press Bell Icon to get automated notifications whenever new video is uploaded.

Must Read

Torrent Power acquires 156 MW wind power plants from CESC for Rs 790 Cr

Torrent Power acquires 156 MW wind power plants from CESC for Rs 790 CrTorrent Power has entered into a...

Wipro GE Healthcare launches ‘Made in India’ CT System to strengthen access to quality healthcare across India

Wipro GE Healthcare launches ‘Made in India’ CT System to strengthen access to quality healthcare across India Wipro GE Healthcare...

U.S based Amneal Pharma acquires India’s Punishka Healthcare for Rs 700 Cr

U.S based Amneal Pharma acquires India's Punishka Healthcare for Rs 700 CrAmneal Pharmaceuticals today announced it has acquired Puniska...

MARPOSS eyes India’s thriving biomedical market

Today, we introduce Federico Poli, the Biomedical Group Industry Manager at Marposs. Recently, during his visit to Mumbai, he engaged in a candid conversation with Subhajit Roy from the mojo4industry channel. Their discussion revolved around the growing biomedical industry and Marposs’s significant role within it.

Poli emphasized the expansive nature of the biomedical market, particularly in India, where efforts are underway to foster growth. He mentioned promotional activities, strategic planning, and engagements with customers seeking classification, inspection, and quality assurance for biomedical components.

How impactful is Marposs’ presence in the biomedical field compared to its established ventures in the automotive, HVAC, and aerospace industries?
We are actively expanding our presence in the burgeoning biomedical market in India. We cater to those seeking reliable classification, inspection, and quality assurance for biomedical components through promotion, strategic planning, and customer engagement. Our focus spans both disposable hospital applications and implants. Our solutions encompass technical verification, inspection, leak, and flow testing, as well as automation and software control.

Which global companies do you collaborate with in this industry?
We are actively collaborating with dedicated professionals specializing in the biomedical sector. While we engage with the top ten industry leaders, we are also expanding our portfolio by evaluating and potentially qualifying a select few additional partners.

How do you envision the growth of the disposable and implant sectors, particularly in emerging markets like India?
India serves as a key starting point for our expansion into the biomedical sector, which we aim to strengthen. Given the significant manufacturing capacity for disposables in India, we are keen to enhance our presence. We are particularly focused on developing solutions for extruded tubes, as well as products like feeding bags, urine bags, air circulators, and oxygen masks.

How can Indian companies, such as HMD, collaborate with Marposs to make their mark in the global market?
We are currently working on a syringe inspection solution in collaboration with a competitor of HMD. With HMD, we have already developed a stable and effective syringe inspection solution covering diameter, thickness, and leak testing. During our potential meeting with HMD, we will showcase our extensive portfolio of solutions.

What message do you have for your customers in India and potential customers in this industry?
We are Marposs, with six convenient locations across India, extending our reach globally. Our team of experts boasts a wealth of knowledge ready to be shared with you. Offering solutions for both disposable and implantable medical devices, we invite you to connect with us. Let’s collaborate and explore new avenues for profitable business together.

To wrap up, why does Marposs consider India a target market for the biomedical industry?
India stands out as a leading hub for technological advancements and manufacturing capabilities worldwide. With its diverse regions and numerous manufacturing centers, it offers lucrative business opportunities. At Marposs, we aim to align closely with your needs and applications in this growing market.

How will Marposs solutions and services benefit customers in the biomedical industry?
Many OEMs and users may not realize the need for updated classification, inspection, and quality certification. With Marposs, you can certify 100% of your production through both manual and automatic controls. We offer the flexibility to adapt to new classification standards and regulations, whether they’re from Asia, Europe, or America. For instance, in the US, compliance with strict FDA regulations is crucial for certain end-users. With Marposs, you can ensure the quality inspection of your manufactured components, meeting the evolving needs of your end-users.

Tune in to the interview now!

Subscribe to our Newsletter

Keep up with the latest industry news in India and around the world by subscribing to our industrial news update. This way, you'll always be in the know about what's happening in your industry, and you can stay ahead of the competition.

Digital Vs Print Media
mojo4industry on google news

Tech Talks

00:04:19

Why polyurethane is good for construction?

Why polyurethane is good for construction? #construction #polyurethane #sustainabilityPolyurethane, often referred to simply as PU, is making waves in...
mojo4industry podcast episodes click here to listen